After an incredible run, lumber prices have been tumbling. Gold prices, meanwhile, have held up much better. Is it time to get defensive?
Shares of DiDi Global (NYSE: DIDI), Alibaba (NYSE: BABA), and NetEase (NASDAQ: NTES) were all rising today on no company-specific news. All of these China-based companies are likely seeing their share prices jump today after a major sell-off of Chinese tech stocks over the past couple of weeks. DiDi's stock was up 9.3%, Alibaba popped 4.9%, and NetEase's share price spiked 12.6% as of 2:15 p.m. EDT.
The restaurateur posted earnings, which were actually pretty good. But it seems there was other news investors didn't like.
Flora Growth (NASDAQ: FLGC) surged as high as $7.95 in afternoon trading Wednesday, a rise of more than 50% to the highest level the stock has touched since its initial public offering in May. Colombia-based Flora, which just announced plans to move its corporate headquarters to Miami from Canada, cultivates cannabis and processes it into medicinal-grade cannabis oil and other products, which it supplies to pharmacies, cosmetics companies, and medical clinics. The cream, already sold in Canada, will now also be sold through Flora's distribution channels in Latin America.
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons’ Euclidean Capital. If you want to skip our detailed analysis of Simons’ history, investment philosophy, and hedge fund performance, go directly to the 5 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean […]
Shares of Advanced Micro Devices (NASDAQ: AMD) are rising today, up by 6.4% as of 12:12 p.m. EDT, after the semiconductor company reported Q2 2021 earnings that beat analyst predictions with a stick. When calculated according to generally accepted accounting principles (GAAP), of course, AMD's numbers weren't quite as good as those pro forma numbers suggest -- but they were good enough. Gross profit margin jumped 4 full percentage points to 48%, and operating profit margin more than doubled to 22%.
Shares of New York Community Bancorp (NYSE: NYCB) traded nearly 10% higher as of 12:15 p.m. EDT after the bank reported earnings results for the second quarter of 2021. New York Community Bancorp, a bank with assets of nearly $58 billion that specializes in multifamily lending, generated diluted earnings per share (EPS) of $0.30 on total revenue of $347 million. EPS would have been $0.33 for the quarter if you exclude one-time, non-recurring tax charges and $10 million of expenses related to New York Community Bancorp's planned acquisition of Flagstar Bancorp (NYSE: FBC), which will bring the combined bank to $87 billion in assets.
Growth stocks are moving, and the popular ETF money manager is making moves. Let's dive into her shopping list to see some of the stocks she bought on Tuesday.
In this article, we discuss the 15 best strong buy stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Strong Buy Stocks to Invest In. Uncertainty has been clouding over the stock market in the United States as investors exercise caution in the […]
(Bloomberg) -- Another double-digit share price rally could be in store for Cassava Sciences Inc. over the next month, as the biotech vies with retail trading favorites AMC Entertainment Holdings Inc. and GameStop Corp. to be the year’s top-performing stock in the Russell 3000.In the run-up to the big reveal from a mid-stage study, the 23-year old drug developer has sprinted more than 1,700% this year. On July 29, Cassava is expected to present safety and cognition data from about 50 people with
What happened Wednesday is shaping up to be a profitable day for cannabis investors. Here's how some of the most popular pot stocks were performing as of 12:30 p.m. EDT today: Sundial Growers (NASDAQ: SNDL), up 10% OrganiGram Holdings (NASDAQ: OGI), up 9% Aurora Cannabis (NASDAQ: ACB), up 8% Canopy Growth (NASDAQ: CGC), up 7% Hexo (NYSE: HEXO), up 7% So what The gains were sparked by a blockbuster earnings report from industry heavyweight Tilray (NASDAQ: TLRY).
Myles Udland, Brian Sozzi, and Julie Hyman breakdown more earnings which include: Spotify quarterly revenue beating despite missing user target, Boeing stock seeing a surge after reporting its first profit in 2 years, and Pfizer raising guidance as COVID vaccine is expected to generate more revenue.
In this article, we discuss the 15 best gambling stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Gambling Stocks to Buy Now. In 2020, as a result of the lockdown in reaction to the global pandemic, several brick-and-mortar casinos saw a sharp drop in […]
As the world becomes more digital, the financial sector is subject to new innovations. These two companies are changing the game.
Stock market investors have had a tough time lately, and Wednesday's moves showed how different readings on the broader global economy are making it hard for investors to interpret what's going on. Amid widespread confusion about how much to worry about a new flare-up of COVID-19 cases and the potential impact on the economic recovery, markets were largely mixed Wednesday morning. On a day packed with corporate earnings releases, a couple of stocks stood out.
Brian Sozzi, Julie Hyman and Myles Udland discuss big tech earnings which include: Microsoft raising revenue forecast after topping earnings, Alphabet beating estimates on a strong wave of advertising growth, and Apple reporting a blowout quarter as the global chip shortage creeps up on the tech company.
House Speaker Nancy Pelosi says Congress needs to pass legislation, a day after Senate Majority Leader Chuck Schumer advocated forgiveness from the president's pen.
Infinity Pharmaceuticals Inc (NASDAQ: INFI) has issued data updates from two mid-stage trials for eganelisib, its oral immuno-oncology candidate. Data: 49 patients were enrolled in the MARIO-275 study designed to evaluate it as a combination therapy with Bristol-Myers Squibb Co's (NYSE: BMY) Opdivo (nivolumab) in platinum-refractory, I/O naïve patients with advanced urothelial cancer. In the combination arm, the median overall survival (mOS) in the intent to treat (ITT) population stood at 15.4
In this article, we will be looking at the 10 best dividend aristocrats with over 4% yield. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 Best Dividend Aristocrats with Over 4% Yield. According to data from a book called Active Value Investing: Making Money in […]
Elon Musk earlier this week made his most bullish statements yet on iron-based batteries, noting that Tesla is making a “long-term shift” toward older, cheaper lithium-iron-phosphate (LFP) cells in its energy storage products and some entry-level EVs. The Tesla CEO mused that the company's batteries may eventually be roughly two-thirds iron-based and one-third nickel-based across its products. Musk's comments reflect a change that is already underway within the automotive sector, mainly in China.
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of March 31st. The results of that effort will be put on display in this article, as […]